SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Timoteo who wrote (697)2/26/2000 6:20:00 PM
From: david james   of 1298
 
Yes, after you subtract out the cash and the ABGX shares they own there isn't much valuation on the rest of the company. That is pretty remarkable for a company that has finished very promising Phase I and Phase II trials on vaccines for both prostate and lung cancer (trials performed at Harvard). And Japanese tobacco is betting at least $45 mill that these vaccines are going to work.

And of course, there are the 200 plus patents. I suspect we go up to the next level next week and then do another shake out like we did this last week.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News